Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

Anti-CD19, Humanized Antibody

Biosimilar to Inebilizumab, monoclonal antibody that targets CD19
Catalog #: A2173
$455.00

Product Details

Cat # +Size A2173-100
Size 100 μg
Antibody Target CD19
Alternate Name B-lymphocyte surface antigen B4, T-cell surface antigen Leu-12, CVID3, B4
Host Recombinant
Antibody Type Monoclonal
Isotype IgG1, kappa
Immunogen Human CD19
Accession # DB12530
Appearance Colorless liquid
Formulation In PBS, pH 7.5
Purification Protein A purified
Species Reactivity Human
Handling The antibody solution should be gently mixed before use.
Storage Conditions -80°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.

Details

The research-grade biosimilar is a humanized afucosylated monoclonal antibody that is directed against CD19. CD19 is a cell surface antigen that is expressed on pre-, mature and malignant B lymphocytes. It is required for proliferation, differentiation, activation of B cells, and antibody production


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.